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Abstract
Background
In adults, arterial stiffness measured by pulse wave velocity (PWV) is regarded as a predic-
tor of cardiovascular disease. Infant vascular development depends on factors related to
pregnancy, including maternal blood pressure (BP). This study assessed the association
between maternal BP in pregnancy and infant brachio-femoral PWV at age 2–6 weeks.
Methods
The Baby Vascular health and Iron in Pregnancy (Baby VIP) study is a birth cohort which
measured PWV and heart rate (HR) in 284 babies in Leeds, UK, at 2–6 weeks after birth.
Maternal BP measurements at 12 and 36 weeks gestation was collected from antenatal clin-
ical records. Multivariable linear regression models assessed associations between mater-
nal systolic and diastolic BPs, and BP change from booking to 36 weeks, with infant PWV
adjusting for covariables at both mother and baby level.
Results
There was no evidence of an association between infant PWV and maternal systolic BP at
booking (adjusted regression coefficient -0.01 m/s per 10mmHg, 95% CI -0.11, 0.14, p =
0.84) or at 36 weeks (adjusted regression coefficient 0.00 m/s per 10mmHg, 95% CI -0.12,
0.11, p = 0.95). Change between 12 and 36 weeks gestation of more than 30 mmHg in sys-
tolic BP or 15 mmHg in diastolic BP was also not associated with infant PWV. There was an
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inverse relationship between infant HR and infant PWV (regression coefficient -0.14 m/s per
10 bpm, 95% CI -0.22, -0.05, p<0.01).
Conclusions
This study has shown no evidence of association between infant PWV at 2–6 weeks of age
and maternal BP in early or late pregnancy. Infant HR was inversely associated with infant
PWV. Further studies are required to determine the predictors of infant PWV as well as the
importance and long term implications of PWV measurements in infants.
Introduction
Adult aortic pulse wave velocity (aPWV) is an independent predictor for cardiovascular events
in adults [1, 2]. The measurement of PWV is a simple, non-invasive and reproducible method
to determine arterial stiffness [1], and in adults displaces systolic blood pressure (SBP) or pulse
pressure as a predictor for cardiovascular disease mortality. An increase in arterial stiffness can
cause premature return of reflected waves in late systole, consequently increasing central pulse
pressure and SBP. Increased SBP increases the myocardial oxygen demand by increasing the
load on the left ventricle of the heart, and arterial stiffness has been associated with LVH [3, 4].
In both normotensive and hypertensive adults, LVH is another independent predictor of coro-
nary events [5, 6].
The influence of events that occur early in fetal life and their effects on cardiovascular risk
in adulthood has been of significant interest [7]. It is well established that reliable measure-
ments of BP are feasible in childhood with normal ranges established [8]. Epidemiological
studies have shown a negative association between birth weight and childhood SBP [9–11] as
well as an increased risk for the hypertension in adult life for those whose birth weight was low
[12]. One study demonstrated a relationship between birth weight and pulse pressure in ado-
lescents, which was measured in the arm over 24 hours as an estimate of arterial stiffness [13].
A subsequent study showed that children with the lowest birth weights have early wave return
which depended on the PWV, suggesting an early reduction in the elastic properties of the
arteries [13].
Infant and childhood vascular development and BP is in part dependent on factors during
pregnancy, including maternal BP [14–17]. The relationship between physiological maternal
and infant BP is however largely unknown [18, 19]. One large systematic review has shown a
link between maternal chronic hypertension and adverse pregnancy outcomes, including pre-
eclampsia, preterm delivery, low birth weight and neonatal death [20]. Children of women
with extremes of hypertension in pregnancy, for example, those with pre-eclampsia, have
higher BP and an increased risk of vascular events later in life [15, 17]. Determinants of cardio-
vascular disease, for example BP and PWV may be linked to fetal adaptations later manifest in
life; for example, infant PWV has been shown to be associated with birth weight [21, 22].
Maternal BP may be a marker of not only birth weight [23, 24], but also neonatal BP and
PWV.
There is strong evidence showing the relationship between extremes of high BP and poor
obstetric and neonatal outcomes [20]. However, for women with BP within the ‘normal’ range,
the transmission of this risk is less well known and there are fewer studies exploring the mater-
nal BP within this ‘normal’ range and subsequent effects on offspring. Koudsi et al performed
a study of 148 babies and found that infant aPWV may be a useful index of infant vascular
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status, and was better tolerated than BP monitoring; contrary to their hypothesis, they found
an inverse relationship between maternal SBP and neonatal aPWV [22].
The aim of this study was to explore the relationship between infant brachio-femoral PWV
(bfPWV) at 2–6 weeks of age and maternal systolic and diastolic BP in early and late
pregnancy.
Materials and methods
Study design
We used data from the Baby VIP (Baby’s Vascular Health and Iron in Pregnancy) birth cohort
study. The primary aim of the Baby VIP study was to examine the association between mater-
nal iron status in pregnancy with infant brachio-femoral PWV and birth outcomes [25, 26].
However, given the previous evidence by Koudsi et al that maternal BP is a predictor of infant
PWV (22), and the limited published evidence on predictors of infant arterial stiffness, we
sought to conduct this analysis. The cohort recruited women aged18 years who gave birth in
the Leeds Teaching Hospitals Trust Maternity Unit at a gestational age of34 weeks between
February 2012 and January 2013. Participants were recruited from the postnatal wards, and if
agreeable to participation, were then asked if a member of the research team could contact
them after they were discharged to arrange a home visit within six weeks of discharge. Ethical
approval was obtained from the South Yorkshire Committee of the NHS National Research
Ethics Service (11/YH/0064) to conduct this study and the University of Southampton
Research Ethics Committee (ERGO ID: 20315) to perform this analysis. The study conformed
to the 1975 Helsinki Declaration, revised in 1983.
Outcome measurement
Brachio-femoral (bfPWV) was measured using an oscillometric device (Vicorder, Skidmore
Medical). This is a non-invasive approach which has been shown to be relatively independent
of operator skills, with reproducible results [27, 28]. The arm cuff was sited at the midpoint of
baby’s arm, and the leg cuff at the midpoint of the ipsilateral thigh. Transit time was measured
as the time delay between the feet of the proximal and the distal pulse waves. A minimum of
two bfPWV readings were taken for each baby, and if there was more than 0.3m/s difference
in the readings, a third one was taken. The average PVW reading for each baby was used in the
analysis. All measurements for each baby was performed at the same visit, usually separated by
a few minutes. The detailed methods for measuring this outcome variable have been described
elsewhere [25].
Exposure measurement
Maternal blood pressures measurements taken by the midwife at each participant’s first ante-
natal visit (‘booking’) and at 36 weeks gestation were extracted from the antenatal care records.
The method of measurement is likely to have followed the National Institute for Health and
Care Excellence (NICE) antenatal care guidelines for blood pressure measurement in preg-
nancy [29]. A cut off of140 mm Hg and 90 mm Hg were used to indicate ‘hypertension’
for systolic and diastolic measurements respectively. These cut-off values were based on the
Hypertension in Pregnancy Guideline from NICE [30]; they class a BP of 140/90 to 149/99
mm Hg as mild hypertension, BP of 150/100 to 159/109 mm Hg as moderate hypertension,
and BP of 160/110 mm Hg or higher as severe hypertension. However, hypertension in preg-
nancy can also be diagnosed as a relative rise above measurements obtained at booking; the
definition for this is either a rise in systolic BP of>30 mmHg or rise in diastolic BP of>15
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mm Hg above the BP at booking [31]. Therefore, we also calculated the change in systolic and
diastolic blood pressure measurements between booking and at 36 weeks gestation.
Covariable assessment
The Index of Multiple Deprivation (IMD) is derived from GeoConvert which uses UK census
data (geoconvert.mimas.ac.uk). Covariables including birth weight, gestational age, parity,
maternal height, weight ethnicity, smoking status, pregnancy complications (pre-eclampsia,
gestational diabetes), blood pressure measurements and oral iron supplement intake were
extracted from the clinical health records. Infant heart rate was recorded by the Vicorder
device and used in the analysis if there were at least two measurements documented in the
database. The average of these two independent readings was used in the statistical models.
Statistical methods
Statistical analysis was performed using Stata version 14 (2016; College Station, Tex., USA).
We assessed the relationship between infant PWV as the outcome variable and maternal BPs
as the predictors using regression analyses. Initially univariable (no adjustment for covariables)
analyses were undertaken, followed by multiple linear regression models that first adjusted for
the possible confounders, then adjusted for the aformentioned confounders and infant heart
rate. The confounders adjusted for included baby covariables (gestational age (days), birth-
weight (grams), feeding status, age at measurement of PWV, baby’s position, sleep/wake phase
and sex) and maternal covariables (maternal age, smoking status, ethnicity, BMI, IMD score,
parity and presence of gestational diabetes). A statistical significance level of 5%, with 95%
confidence intervals was used in the regression models. In addition, we planned to use multi-
ple linear regression models to assess infant heart rate (HR) as a potential mediator of any
potential significant association between infant PWV and maternal BP. The infant HR was
taken from a mean of two readings.
Study power
The original sample size calculation for this cohort is described elsewhere (25). Retrospective
study power calculation for this analysis was performed. For a study power of 80% at a statisti-
cal significance level of 0.05, using the mean (6.7 m/s) and standard deviation (1.3 m/s) of
PWV from this study, a sample size of 270 mother-baby pairs is required to detect a difference
of 0.44 m/s in bfPWV.
Results
A total of 362 mother-baby pairs were recruited into the study, and 284 (79%) babies had a
PWV measurement at a follow up home visit. A total of 276 mother-baby pairs had infant bf-
PWV measurements and maternal BP readings at booking and at 36 weeks gestation. Mean
infant PWV was 6.7 m/s (95% CI 6.5–6.8). At booking the mean maternal systolic and diastolic
BP readings were 112 mmHg (95% CI 110–113) and 67 mmHg (95% CI 66–68). A 36 weeks
gestation, the mean maternal systolic and diastolic BP readings were 116 mmHg (95% CI 115–
118) and 71 mmHg (95% CI 70–72). Table 1 describes the characteristics of the participants,
categorised by group with maternal systolic BP reading of 140 mmHg or<140mmHg.
The results for the univariable analyses and multiple linear regression analyses, adjusting
for confounders and mediators are shown in Tables 2–4. In unadjusted analyses, there was no
evidence of significant associations between infant bfPWV and maternal systolic or diastolic
BP at either booking or 36 weeks gestation (Table 2). For every 10mmg increase in systolic BP
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at booking, there was no evidence of a statistically significant change in the bfPWV (adjusted
regression coefficient 0.01, 95% CI -0.11, 0.14, p = 0.84). For every 10mmg increase in diastolic
BP at booking, there was no evidence of a statistically significant change in the bfPWV
(adjusted regression coefficient 0.03, 95% CI -0.14, 0.20, p = 0.72). For every 10mmg increase
in systolic BP at 36 weeks gestation, there was no evidence of a statistically significant change
in the bfPWV (adjusted regression coefficient 0.00, 95% CI -0.12, 0.11, p = 0.95). For every
10mmg increase in diastolic BP at 36 weeks gestation, there was no evidence of a statistically
significant change in the bfPWV (adjusted regression coefficient 0.02, 95% CI -0.12, 0.15
p = 0.80).
There was no evidence of an association between infant bfPWV and maternal systolic
hypertension (140 mmHg) at booking (adjusted regression coefficient -0.19, 95% CI -1.14,
0.75, p = 0.69) or at 36 weeks gestation (adjusted regression coefficient -0.37, 95% CI -1.11,
0.37, p = 0.33) (Table 3). There was no evidence of an association between infant bfPWV and
maternal diastolic hypertension (90 mmHg) at booking (adjusted regression coefficient 0.86,
95% CI -0.21, 1.93, p = 0.12) or at 36 weeks gestation (adjusted regression coefficient –0.10,
95% CI -1.04, 0.83 p = 0.83) (Table 3). There was also no evidence of an association between
Table 1. Baby VIP Study sample characteristics categorised by maternal systolic blood pressure at 36 weeks gestation.
Characteristic Maternal systolic BP 140 mmHg at 36
weeks (n = 14)
Maternal systolic BP <140 mmHg at 36
weeks (n = 262)
P value
Mean, Standard Deviation
Maternal age, yrs (n = 276) 30.5 6.4 31.0 5.5 0.7
Maternal BMI, kg/m2 (n = 273) 32.6 8.0 26.2 5.8 <0.001
Age of PWV measurement, days (n = 275) 27.1 0.5 24.4 0.4 0.1
Baby’s birthweight, g (n = 276) 3069 559 3381 609 0.06
Baby’s heart rate, beats/min (n = 207) 117 23 117 19 1.0
Baby’s PWV, mmHg (n = 276) 6.4 1.1 6.7 1.3 0.4
Baby’s gestational age at birth, days (n = 276) 274 14 278 13 0.2
N (%) of cases, 95% CI
Parity (n = 276)
Nulliparous (n = 143) 8 (57.1) 28.9, 82.3 135 (51.5) 45.3, 57.7 1.0
Multiparous (n = 133) 6 (42.9) 17.7, 71.1 127 (48.5) 42.3, 54.7
Smoking status
Never smoked (n = 153) 5 (35.7) 12.8, 64.9 148 (56.5) 50.2, 62.6 0.3
Smoker (n = 36) 2 (14.3) 1.8, 42.8 34 (13.0) 9.2, 17.7
Ex-smoker (n = 87) 7 (50.0) 23.0, 77.0 80 (30.5) 25.0, 36.5
Ethnicity
White British (n = 216) 12 (85.7) 57.2, 98.2 205 (77.9) 72.3, 82.7 0.9
Other ethnicity (n = 60) 2 (14.3) 1.8, 42.8 58 (22.1) 17.3, 27.7
Presence of diabetes
Yes (n = 4) 0 (0) 0, 23.2 4 (1.5) 0.4, 3.9 0.6
No (n = 272) 14 (100) 76.8, 1 258 (98.5) 96.1, 99.6
Method of feeding
Breastfeeding (n = 120) 5 (35.7) 12.8, 64.9 115 (43.9) 37.9, 50.2 0.7
Bottle feeding (n = 106) 7 (50.0) 23.0, 77.0 99 (37.8) 32.0, 44.0
Mixed feeding (n = 50) 2 (14.3) 1.8, 42.8 48 (18.3) 13.8, 23.5
Complete cases for exposures, outcomes, confounders and mediators. Where there was a continuous variable, a t-test was used for analysis, and where there was a
categorical variable, a chi-squared test was used.
https://doi.org/10.1371/journal.pone.0200159.t001
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infant bfPWV and a change in systolic BP from booking to 36 weeks (>30 mmHg increase)
(adjusted regression coefficient -0.52, 95% CI -1.26, 0.22, p = 0.16) or a change in diastolic BP
from booking to 36 weeks (>15 mmHg increase) (adjusted regression coefficient 0.19, 95% CI
-0.28, 0.66, p = 0.42) (Table 4).
There was no evidence of significant associations between maternal BP parameters and
bfPWV, when adjusting for infant HR as well as confounders (Tables 2–4).
There was an inverse relationship between infant HR and infant PWV. The regression
coefficient of the relationship is a PWV of -0.14m/s per every 10bpm increase in infant HR,
95% CI -0.22, -0.05, p<0.01 (Adjusted regression coefficient -0.11, 95% CI -0.20, -0.02,
p = 0.01). The adjusted model included maternal age, smoking status, ethnicity, BMI at
booking, parity, IMD score, presence of gestational diabetes, baby’s gestational age, birth-
weight, gender, type of feeding, age at PWV measurement, position and whether asleep or
awake at the time of measurement.
Table 2. Associations between infant pulse wave velocity and maternal blood pressure as a continuous variable in the Baby VIP Study.
Predictor Difference in infant bfPWV (m/s),
unadjusted
Difference in infant bfPWV (m/s),
adjusted for confounders
Difference in infant bfPWV (m/s),
adjusted for confounders and infant HR
Mean
difference
95% CI P-value Mean
difference
Adjusted 95%
CI
P-value Mean
difference
Adjusted 95%
CI
P-value
Maternal systolic BP at booking
(mmHg)
0.03 -0.09,
0.15
0.61 0.01 -0.11, 0.14 0.84 0.03 -0.12, 0.18 0.72
Maternal diastolic BP at booking
(mmHg)
0.07 -0.10,
0.23
0.43 0.03 -0.14, 0.20 0.72 0.00 -0.16, 0.22 0.77
Maternal systolic BP at 36 weeks
(mmHg)
0.03 -0.08,
0.13
0.59 0.00 -0.12, 0.11 0.95 0.04 -0.08, 0.17 0.49
Maternal diastolic BP at 36 weeks
(mmHg)
0.02 -0.11,
0.15
0.75 0.02 -0.12, 0.15 0.80 0.03 -0.11, 0.18 0.66
Mean difference in PWV reflects 10mmHg change in BP
Multiple linear regression models were used to determine associations. Confounders include maternal factors (maternal age, smoking status, ethnicity, BMI, IMD score,
parity presence of gestational diabetes) and baby factors (gestational age, birth weight, feeding status, age at measurement of PWV, baby’s position, sleep/wake phase
and sex). Infant HR was assessed as a potential mediator.
https://doi.org/10.1371/journal.pone.0200159.t002
Table 3. Associations between infant pulse wave velocity and maternal hypertension (systolic BP 140 and diastolic BP 90) in the Baby VIP Study.
Predictor Difference in infant bfPWV
(m/s), unadjusted
Difference in infant bfPWV (m/s),
adjusted for confounders
Difference in infant bfPWV (m/s),
adjusted for confounders and infant HR
Mean
difference
95% CI P-
value
Mean
difference
Adjusted 95%
CI
P-
value
Mean
difference
Adjusted 95%
CI
P-
value
Maternal systolic BP 140 mmHg at
booking (n = 7)
-0.21 -1.15,
0.73
0.65 -0.19 -1.14, 0.75 0.69 -0.16 -1.11, 0.80 0.74
Maternal diastolic BP 90 mmHg at
booking (n = 6)
0.94 -0.13,
2.02
0.09 0.86 -0.21, 1.93 0.12 1.09 -0.19, 2.20 0.05
Maternal systolic BP 140 mmHg at 36
weeks (n = 14)
-0.30 -1.01,
0.42
0.41 -0.37 -1.11, 0.37 0.33 0.20 -0.66, 1.05 0.65
Maternal diastolic BP 90 mmHg at 36
weeks (n = 8)
-0.09 -1.02,
0.85
0.85 -0.10 -1.04, 0.83 0.83 0.14 -0.88, 1.17 0.78
Multiple linear regression models were used to determine associations. Confounders include maternal factors (maternal age, smoking status, ethnicity, BMI, IMD score,
parity and presence of gestational diabetes) and baby factors (gestational age, birth weight, feeding status, age at measurement of PWV, baby’s position, sleep/wake
phase and sex). Infant HR was assessed as a potential mediator.
https://doi.org/10.1371/journal.pone.0200159.t003
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Discussion
This study has shown that there is no evidence of any associations between infant PWV and
maternal hypertension in pregnancy, maternal BP as a continuous variable in early and late
pregnancy, or change in maternal BP (>30 mmHg in SBP or 15 mmHg in DBP between early
and late pregnancy). Infant HR was inversely associated with infant PWV.
These findings do not support Koudsi et al’s study findings which showed an inverse rela-
tionship between maternal SBP at 28 weeks gestation and neonatal aortic PWV [22]. There are
some potential reasons for the difference in our findings to this previous study. Koudsi et al’s
study was performed on 148 mothers and neonates, it looked at the PWV in neonates in the
first few days of life only, and they only investigated the association with maternal SBP at 28
weeks gestation [22]. They performed a reproducibility study on 30 infants only, and con-
cluded that the aortic PWV method was reliable, giving similar readings at baseline and up to
3 days later. They used this to justify that a mean PWV result was not necessary. Our study
expands on the study done previously by Koudsi et al [22]; it includes a larger sample size of
mothers and infants, we take the mean PWV measurements from two or three readings
(where the mean measurement is used for analysis), the PWV is measured between 2–6 weeks
of age and we include associations with maternal BP measurements at booking, and at 36
weeks gestation. We also assessed the association of an increase in the systolic and diastolic BP
from booking to 36 weeks gestation with infant PWV. We performed a sensitivity analysis
where we adjusted for the infant HR in association with maternal BP and infant PWV. Infant
HR cannot be considered a true confounder as it cannot directly influence maternal BP, and
therefore was not included in the main model.
Our study reports an average bf-PWV of 6.7 m/s, which is higher than that reported by
other studies which have assessed the aortic PWV in the immediate postnatal period [22] and
those in slightly older infants and young children [32]. This may be explained by the use of
peripheral arteries (namely the brachial and the femoral) in our study, which are ‘muscular
arteries’, containing fewer elastic fibers and more smooth muscle cells than conducting ‘elastic
arteries’ such as the aorta. Less elastic fibers within the tunica media of an artery will mean less
distensability when a pulse wave is passed, and an increased arterial stiffness, reflected by the
higher PWV in this study. In adults, the brachio-ankle PWV is higher than the carotid-femoral
PWV by approximately 20% [33].
Environmental exposure in utero is known to have significant impacts on the developmen-
tal health and wellbeing of the offspring later on in life [7, 34]. In the human, the hemochorial
Table 4. Associations between infant pulse wave velocity and a significant change in maternal BP from booking to 36 weeks gestation (change in systolic BP
>30mmHg and change in diastolic BP>15mmHg) in the Baby VIP Study. Out of 276 subjects, 13 (5%) had a change in systolic BP>30 mmHg and 35 (13%) had a
change in diastolic BP>15mmHg.
Predictor Difference in infant bfPWV (m/s),
unadjusted
Difference in infant bfPWV (m/s),
adjusted for confounders
Difference in infant bfPWV (m/s),
adjusted for confounders and infant HR
Mean
difference
95% CI P-value Mean
difference
Adjusted 95%
CI
P-value Mean
difference
Adjusted 95%
CI
P-value
Change in systolic BP >30mmHg
(n = 13)
-0.34 -1.08,
0.40
0.37 -0.52 -1.26, 0.22 0.16 -0.16 -1.18, 0.86 0.76
Change in diastolic BP >15mmHg
(n = 35)
0.21 -0.26,
0.68
0.37 0.19 -0.28, 0.66 0.42 0.25 -0.28, 0.78 0.36
 Change in blood pressure from BP measurement at booking to measurement at 36 weeks gestation.
Confounders include maternal factors (maternal age, smoking status, ethnicity, BMI, IMD score, parity and presence of gestational diabetes) and baby factors
(gestational age, birth weight, feeding status, age at measurement of PWV, baby’s position, sleep/wake phase and sex). Infant HR was assessed as a potential mediator.
https://doi.org/10.1371/journal.pone.0200159.t004
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placenta allows the fetal tissues to interact directly with the mother’s blood, allowing rapid dif-
fusion of nutrients and oxygen to the fetus; thus, effects on maternal vasculature and placental
vascular function have the potential to be translated to the fetus. There is also evidence to show
that infant and childhood vascular development is dependent on factors related to pregnancy
including BP [14–17]. Despite convincing evidence to suggest a plausible relationship, we have
shown no associations between maternal hypertension, or maternal blood pressure antenatally
and infant PWV. This may be a ‘true no association’ or may be type 2 error due to insufficient
statistical power. There may be non-differential information bias, for example, most babies
could not remain completely still during the PWV measurement causing random measure-
ment error. Additionally, our study has used a ‘healthy’ population, mostly with normal blood
pressures and so the effect of ‘true pathology’ (for example higher degrees of hypertension), on
infant PWV may remain concealed in this study.
It remains unclear how maternal blood flow and the integrity of the vasculature affects arte-
rial growth and development in the neonate. Mechanical properties of the arterial walls depend
on extracellular matrix components produced by smooth muscle cells [35]. Elastin and pro-
teins including lysyl oxidase, fibrillians and fibulins, have the highest expression during the
late embryonic and neonatal period (with minimal expression during adulthood) [35] and
allow arteries to maintain sufficient blood pressures.
In this study, we showed an inverse relationship between infant heart rate and PWV, which
is contrary to positive relationship between the two variables in the analysis by Koudsi et al
[22]. In adults, it is recognised that arterial stiffness (higher PWV) is associated with a higher
resting heart rate [36], however, this relationship in infants is not widely explored and different
physiological mechanisms in the newborn may explain our findings. There are complex neu-
rohumoral and metabolic responses maintaining blood pressure and heart rate in the new-
born. For example, in later gestations in the fetus and the newborn, there is decreasing HR as
blood pressure rises due to baroreceptor activity, which is particularly sensitive to changes in
BP in the aortic arch and carotid sinuses.
There are some limitations of our study. We used bf-PWV measurements, rather than aor-
tic PWV or other centrally located PWV measurements (e.g. carotid artery), which may be a
potential source of error [37]. The Vicorder device has been used in this study to assess arterial
stiffness using bfPWV. In a study to compare PWV measurements using the Vicorder and the
SphygmoCor devices in 156 children, Keehn et al illustrate that the Vicorder gives good repeat-
ability in children with close correlation of values obtained using the brachio-femoral and
carotid-femoral paths, however, the latter values were only moderately correlated with the
those obtained using the ShygmoCor system making the Vicorder a potentially less accurate
method of assessing PWV in children [38]. However, given its ease of use and reproducibility,
differences are still likely to discriminate between groups with differing arterial stiffness, par-
ticularly if utilised in population studies using relatively large study numbers.
We used the measurement of distance between the two arterial sites as a proxy for the dis-
tance that the pulse wave travels, which may be a source of error. This potential source of error
can be overcome by using magnetic resonance imaging (MRI) to measure PWV; MRI allows
accurate measurement of the path length of the pulse wave within the aorta, even in the pres-
ence of a tortuous vessel [39]. We recognise infant BP as a recognised determinant of infant
PWV [22], however, we did not measure infant BP in this study so did not adjust for this vari-
able in our model. We also used routinely-recorded maternal BP measurements performed as
part of antenatal care at specified time points, and acknowledge that this method of assessment
may be less rigorous than if the measurements were taken as part of a research study protocol.
At present, the predictors of infant PWV remain largely unknown. There have been several
observational studies which have tried to address potential influencers of infant PWV. Infant
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PWV has been shown to be affected by birth weight [21, 22]; small for gestational age and
lower birthweights has been linked to a lower infant PWV (lower degree of arterial stiffness)
[21]. Maternal anaemia prior to 20 weeks gestation has been associated with an increased
infant PWV [25]. Neonates of mothers with higher haemoglobin A1c have a higher PWV [40].
Conclusions
Our study does not show any association between maternal hypertension or antenatal blood
pressure measurements and infant PWV. However, this area warrants further investigation,
especially as these findings differ for a previous study. Longer term follow up of these babies
through to childhood and adult life may help us assess the usefulness of infant PWV as a non-
invasive tool in predicting cardiovascular events later in life. This study has demonstrated fea-
sibility of taking bf-PWV measurements in a relatively large sample of infants in our
population.
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